Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Completed 24Recruiting 16Active not recruiting 11Unknown 9Terminated 8Not yet recruiting 5Withdrawn 2Suspended 1

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 8Gastrointestinal 6Lymphoid 5Tumor-Agnostic 4Thoracic 2Plasma cell 1Myeloid 1Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 65Lymphoma 59Lymphoma, Follicular 53Lymphoma, Large B-Cell, Diffuse 51Lymphoma, B-Cell 50Leukemia, Lymphocytic, Chronic, B-Cell 34Lymphoma, Non-Hodgkin 33Recurrence 27Leukemia 22Lymphoma, Mantle-Cell 20Burkitt Lymphoma 18Lymphoma, T-Cell, Peripheral 17Leukemia, Myeloid, Acute 15Hodgkin Disease 15Waldenstrom Macroglobulinemia 14Hematologic Neoplasms 14Lymphoma, B-Cell, Marginal Zone 13Multiple Myeloma 12Lymphoma, T-Cell, Cutaneous 12Lymphoma, Extranodal NK-T-Cell 12Neoplasms 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, B-Cell 8Motor Activity 7Myelodysplastic Syndromes 6Mycosis Fungoides 6Sezary Syndrome 5Neoplasm, Residual 5Pain 4Neoplasms, Plasma Cell 4

Interventions

blinatumomab 1Vincristine 1Transplantation 1Radiotherapy 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Methotrexate 1Dexamethasone 1Cytarabine 1Cyclophosphamide 1BEBT-908 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Neoplasm, Residual × Lymphoid × Clear all
NCT07517705 2026-05-13

MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma

University of Nebraska

Phase 2 Not yet recruiting
50 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual

NCT07507318 2026-04-02

DEL-MRD-CHID

Fudan University

Phase 2 Not yet recruiting
69 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual

NCT07483476 2026-03-19

CIRCALL

Assistance Publique - Hôpitaux de Paris

Not yet recruiting
205 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07443592 2026-03-02

LAL-2025

PETHEMA Foundation

Phase NA Not yet recruiting
330 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07301138 2025-12-24

BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients

Ruijin Hospital

Phase 2 Not yet recruiting
23 enrolled
LymphoidOther hematologic neoplasm

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡